TY - JOUR
T1 - Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2GoalSM concept
AU - Cohen, O.
AU - Agabria, Z.
AU - Lysyy, L.
AU - Ianovitsky, Y.
AU - Nguyen, X.
AU - Fung, M.
AU - Lee, S.
AU - Wainstein, J.
N1 - Publisher Copyright:
© 2016, Italian Society of Endocrinology (SIE).
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Background: The goal is to assess the usability and satisfaction of implementing the Getting2GoalSM protocol by physicians transitioning patients with type 2 diabetes (T2DM) from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII). Methods: T2DM patients from three diabetes clinics were switched from MDI to CSII. Physicians used the Getting2Goal type 2 pumping protocol to prescribe and manage insulin pump therapy for T2DM. Surveys were conducted in which the physicians rated their feedback related to acceptability of the Getting2Goal on a 5-point Likert scale. Results: 17 patients with T2DM were switched from MDI to CSII treatment. Mean (±standard deviation) age was 61.2 ± 7.7 (46–77) years, weight was 91.4 ± 21 (66–147) kg, BMI was 31.9 ± 7.6, A1C was 9.2 ± 1.4 % (7.2–12.3) and TDD on MDI was 109.1 ± 53.1 units. Surveys completed by physicians indicated Getting2Goal type 2 pumping protocol to be more efficient, time saving, and structured compared to their current processes. In addition, the primarily prescribed TDD on pump was 98.1 ± 50.0 units and the TDD at first download was 81.4 ± 36.4 units, representing a 25.4 % reduction in TDD At first download. The percentage of all blood glucose readings below 70 mg/dL was also very low. Conclusions: The data indicate Getting2Goal materials as a standard approach that is simple and efficient to initiate pump therapy for T2DM. At the same time, it is safe and a useful tool for physicians that are starting to prescribe pump therapy for T2DM.
AB - Background: The goal is to assess the usability and satisfaction of implementing the Getting2GoalSM protocol by physicians transitioning patients with type 2 diabetes (T2DM) from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII). Methods: T2DM patients from three diabetes clinics were switched from MDI to CSII. Physicians used the Getting2Goal type 2 pumping protocol to prescribe and manage insulin pump therapy for T2DM. Surveys were conducted in which the physicians rated their feedback related to acceptability of the Getting2Goal on a 5-point Likert scale. Results: 17 patients with T2DM were switched from MDI to CSII treatment. Mean (±standard deviation) age was 61.2 ± 7.7 (46–77) years, weight was 91.4 ± 21 (66–147) kg, BMI was 31.9 ± 7.6, A1C was 9.2 ± 1.4 % (7.2–12.3) and TDD on MDI was 109.1 ± 53.1 units. Surveys completed by physicians indicated Getting2Goal type 2 pumping protocol to be more efficient, time saving, and structured compared to their current processes. In addition, the primarily prescribed TDD on pump was 98.1 ± 50.0 units and the TDD at first download was 81.4 ± 36.4 units, representing a 25.4 % reduction in TDD At first download. The percentage of all blood glucose readings below 70 mg/dL was also very low. Conclusions: The data indicate Getting2Goal materials as a standard approach that is simple and efficient to initiate pump therapy for T2DM. At the same time, it is safe and a useful tool for physicians that are starting to prescribe pump therapy for T2DM.
KW - CareLink
KW - Continuous subcutaneous insulin infusion
KW - Total daily dose
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=84971393118&partnerID=8YFLogxK
U2 - 10.1007/s40618-015-0407-3
DO - 10.1007/s40618-015-0407-3
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84971393118
SN - 0391-4097
VL - 39
SP - 627
EP - 633
JO - Journal of Endocrinological Investigation
JF - Journal of Endocrinological Investigation
IS - 6
ER -